HEADER HYDROLASE 16-FEB-12 4AJM TITLE DEVELOPMENT OF A PLATE-BASED OPTICAL BIOSENSOR METHODOLOGY TO IDENTIFY TITLE 2 PDE10 FRAGMENT INHIBITORS COMPND MOL_ID: 1; COMPND 2 MOLECULE: CAMP AND CAMP-INHIBITED CGMP 3', 5'-CYCLIC COMPND 3 PHOSPHODIESTERASE 10A; COMPND 4 CHAIN: A, D; COMPND 5 FRAGMENT: CATALYTIC DOMAIN, RESIDUES 439-764; COMPND 6 SYNONYM: PHOSPHODIESTERASE 10A; COMPND 7 EC: 3.1.4.17, 3.1.4.35; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS HYDROLASE EXPDTA X-RAY DIFFRACTION AUTHOR S.GESCHWINDNER,P.JOHANSSON,L.SPADOLA,T.AKERUD,E.BACK,P.HILLERTZ, AUTHOR 2 R.HORSEFELD,C.SCOTT,N.SPEAR,G.TIAN,A.TIGERSTROM,D.AHARONY,J.S.ALBERT REVDAT 2 08-MAY-24 4AJM 1 REMARK LINK REVDAT 1 06-MAR-13 4AJM 0 JRNL AUTH S.GESCHWINDNER,P.JOHANSSON,L.SPADOLA,T.AKERUD,E.BACK, JRNL AUTH 2 P.HILLERTZ,R.HORSEFELD,C.SCOTT,N.SPEAR,G.TIAN,A.TIGERSTROM, JRNL AUTH 3 D.AHARONY,J.S.ALBERT JRNL TITL DEVELOPMENT OF A PLATE-BASED OPTICAL BIOSENSOR METHODOLOGY JRNL TITL 2 TO IDENTIFY PDE10 FRAGMENT INHIBITORS JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 2.40 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.11.1 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.40 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 14.63 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 91.8 REMARK 3 NUMBER OF REFLECTIONS : 24825 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.212 REMARK 3 R VALUE (WORKING SET) : 0.210 REMARK 3 FREE R VALUE : 0.245 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.080 REMARK 3 FREE R VALUE TEST SET COUNT : 1260 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 12 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 2.40 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 2.51 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 91.80 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 2961 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2311 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2822 REMARK 3 BIN R VALUE (WORKING SET) : 0.2309 REMARK 3 BIN FREE R VALUE : 0.2342 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 4.69 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 139 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 5184 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 36 REMARK 3 SOLVENT ATOMS : 105 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 57.97 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 66.18 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 2.46930 REMARK 3 B22 (A**2) : -5.12790 REMARK 3 B33 (A**2) : 2.65860 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.351 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.665 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.277 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.635 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.279 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.943 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.922 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 5347 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 7247 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 1861 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 131 ; 2.000 ; HARMONIC REMARK 3 GENERAL PLANES : 762 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 5347 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : 4 ; 5.000 ; SEMIHARMONIC REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 691 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 6390 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 0.99 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 2.44 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 17.32 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: REFINEMENT NOTES 1: IDEAL-DIST CONTACT REMARK 3 SETUP. RESIDUE TYPES WITHOUT CCP4 ATOM TYPE IN LIBRARY=ZN MG. REMARK 3 NUMBER OF ATOMS WITH PROPER CCP4 ATOM TYPE=5321. NUMBER WITH REMARK 3 APPROX DEFAULT CCP4 ATOM TYPE=0. NUMBER TREATED BY BAD NON- REMARK 3 BONDED USED: 8. REMARK 4 REMARK 4 4AJM COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 16-FEB-12. REMARK 100 THE DEPOSITION ID IS D_1290051327. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 27-OCT-08 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID14-4 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.94 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 210 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 25245 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.390 REMARK 200 RESOLUTION RANGE LOW (A) : 47.840 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 92.2 REMARK 200 DATA REDUNDANCY : 3.000 REMARK 200 R MERGE (I) : 0.07000 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 11.4000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.39 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.45 REMARK 200 COMPLETENESS FOR SHELL (%) : 92.3 REMARK 200 DATA REDUNDANCY IN SHELL : 3.10 REMARK 200 R MERGE FOR SHELL (I) : 0.44000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 2.100 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 43.15 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.16 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: NULL REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 24.99300 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 82.38200 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 40.84700 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 82.38200 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 24.99300 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 40.84700 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ARG A 767 REMARK 465 GLY A 768 REMARK 465 GLU A 769 REMARK 465 GLU A 770 REMARK 465 THR A 771 REMARK 465 ALA A 772 REMARK 465 THR A 773 REMARK 465 TRP A 774 REMARK 465 ASN D 447 REMARK 465 ALA D 448 REMARK 465 GLU D 769 REMARK 465 GLU D 770 REMARK 465 THR D 771 REMARK 465 ALA D 772 REMARK 465 THR D 773 REMARK 465 TRP D 774 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 TYR A 524 -53.32 -123.33 REMARK 500 VAL A 733 -64.88 -121.97 REMARK 500 ARG D 521 45.91 -87.98 REMARK 500 TYR D 524 -54.62 -123.03 REMARK 500 ASP D 579 50.06 39.84 REMARK 500 SER D 615 -170.79 -65.85 REMARK 500 CYS D 676 -13.04 -48.90 REMARK 500 VAL D 733 -63.76 -120.88 REMARK 500 REMARK 500 REMARK: NULL REMARK 600 REMARK 600 HETEROGEN REMARK 600 REMARK 600 COMPLEX WITH COMPOUND AZ13118687 (RESIDUE 3A6) REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 ZN A1402 ZN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 HIS A 529 NE2 REMARK 620 2 HIS A 563 NE2 95.5 REMARK 620 3 ASP A 564 OD2 88.6 86.2 REMARK 620 4 ASP A 674 OD1 87.3 90.6 174.6 REMARK 620 5 HOH A2029 O 164.1 98.1 84.3 100.5 REMARK 620 N 1 2 3 4 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 MG A1403 MG REMARK 620 N RES CSSEQI ATOM REMARK 620 1 ASP A 564 OD1 REMARK 620 2 HOH A2024 O 107.1 REMARK 620 3 HOH A2028 O 82.1 168.8 REMARK 620 4 HOH A2029 O 87.4 81.5 92.7 REMARK 620 5 HOH A2030 O 86.6 111.0 75.4 167.3 REMARK 620 6 HOH A2034 O 163.1 85.7 84.1 83.5 99.3 REMARK 620 N 1 2 3 4 5 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 ZN D1402 ZN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 HIS D 529 NE2 REMARK 620 2 HIS D 563 NE2 94.4 REMARK 620 3 ASP D 564 OD2 85.7 82.9 REMARK 620 4 ASP D 674 OD1 88.3 94.2 173.2 REMARK 620 5 HOH D2026 O 168.3 95.2 89.0 97.5 REMARK 620 N 1 2 3 4 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 MG D1403 MG REMARK 620 N RES CSSEQI ATOM REMARK 620 1 ASP D 564 OD1 REMARK 620 2 HOH D2022 O 78.7 REMARK 620 3 HOH D2025 O 104.8 170.5 REMARK 620 4 HOH D2026 O 94.9 73.3 114.7 REMARK 620 5 HOH D2027 O 87.8 77.8 93.5 149.7 REMARK 620 6 HOH D2033 O 150.7 73.4 101.4 85.8 77.6 REMARK 620 N 1 2 3 4 5 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ZN A 1402 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MG A 1403 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ZN D 1402 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MG D 1403 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 3A6 D 1769 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1LRB RELATED DB: PDB REMARK 900 CATALYTIC DOMAIN OF HUMAN PHOSPHODIESTERASE 10A REMARK 900 RELATED ID: 2WEY RELATED DB: PDB REMARK 900 HUMAN PDE-PAPAVERINE COMPLEX OBTAINED BY LIGAND SOAKING OF CROSS- REMARK 900 LINKED PROTEIN CRYSTALS REMARK 900 RELATED ID: 2Y0J RELATED DB: PDB REMARK 900 TRIAZOLOQUINAZOLINES AS A NOVEL CLASS OF PHOSPHODIESTERASE 10A REMARK 900 (PDE10A) INHIBITORS, PART 2, LEAD-OPTIMISATION. REMARK 900 RELATED ID: 4AEL RELATED DB: PDB REMARK 900 PDE10A IN COMPLEX WITH THE INHIBITOR AZ5 REMARK 900 RELATED ID: 4AJD RELATED DB: PDB REMARK 900 IDENTIFICATION AND STRUCTURAL CHARACTERIZATION OF PDE10 FRAGMENT REMARK 900 INHIBITORS REMARK 900 RELATED ID: 4AJF RELATED DB: PDB REMARK 900 IDENTIFICATION AND STRUCTURAL CHARACTERIZATION OF PDE10 FRAGMENT REMARK 900 INHIBITORS REMARK 900 RELATED ID: 4AJG RELATED DB: PDB REMARK 900 IDENTIFICATION AND STRUCTURAL CHARACTERIZATION OF PDE10 FRAGMENT REMARK 900 INHIBITORS DBREF 4AJM A 449 774 UNP Q9Y233 PDE10_HUMAN 439 764 DBREF 4AJM D 449 774 UNP Q9Y233 PDE10_HUMAN 439 764 SEQADV 4AJM ASN A 447 UNP Q9Y233 EXPRESSION TAG SEQADV 4AJM ALA A 448 UNP Q9Y233 EXPRESSION TAG SEQADV 4AJM ASN D 447 UNP Q9Y233 EXPRESSION TAG SEQADV 4AJM ALA D 448 UNP Q9Y233 EXPRESSION TAG SEQRES 1 A 328 ASN ALA SER ILE CYS THR SER GLU GLU TRP GLN GLY LEU SEQRES 2 A 328 MET GLN PHE THR LEU PRO VAL ARG LEU CYS LYS GLU ILE SEQRES 3 A 328 GLU LEU PHE HIS PHE ASP ILE GLY PRO PHE GLU ASN MET SEQRES 4 A 328 TRP PRO GLY ILE PHE VAL TYR MET VAL HIS ARG SER CYS SEQRES 5 A 328 GLY THR SER CYS PHE GLU LEU GLU LYS LEU CYS ARG PHE SEQRES 6 A 328 ILE MET SER VAL LYS LYS ASN TYR ARG ARG VAL PRO TYR SEQRES 7 A 328 HIS ASN TRP LYS HIS ALA VAL THR VAL ALA HIS CYS MET SEQRES 8 A 328 TYR ALA ILE LEU GLN ASN ASN HIS THR LEU PHE THR ASP SEQRES 9 A 328 LEU GLU ARG LYS GLY LEU LEU ILE ALA CYS LEU CYS HIS SEQRES 10 A 328 ASP LEU ASP HIS ARG GLY PHE SER ASN SER TYR LEU GLN SEQRES 11 A 328 LYS PHE ASP HIS PRO LEU ALA ALA LEU TYR SER THR SER SEQRES 12 A 328 THR MET GLU GLN HIS HIS PHE SER GLN THR VAL SER ILE SEQRES 13 A 328 LEU GLN LEU GLU GLY HIS ASN ILE PHE SER THR LEU SER SEQRES 14 A 328 SER SER GLU TYR GLU GLN VAL LEU GLU ILE ILE ARG LYS SEQRES 15 A 328 ALA ILE ILE ALA THR ASP LEU ALA LEU TYR PHE GLY ASN SEQRES 16 A 328 ARG LYS GLN LEU GLU GLU MET TYR GLN THR GLY SER LEU SEQRES 17 A 328 ASN LEU ASN ASN GLN SER HIS ARG ASP ARG VAL ILE GLY SEQRES 18 A 328 LEU MET MET THR ALA CYS ASP LEU CYS SER VAL THR LYS SEQRES 19 A 328 LEU TRP PRO VAL THR LYS LEU THR ALA ASN ASP ILE TYR SEQRES 20 A 328 ALA GLU PHE TRP ALA GLU GLY ASP GLU MET LYS LYS LEU SEQRES 21 A 328 GLY ILE GLN PRO ILE PRO MET MET ASP ARG ASP LYS LYS SEQRES 22 A 328 ASP GLU VAL PRO GLN GLY GLN LEU GLY PHE TYR ASN ALA SEQRES 23 A 328 VAL ALA ILE PRO CYS TYR THR THR LEU THR GLN ILE LEU SEQRES 24 A 328 PRO PRO THR GLU PRO LEU LEU LYS ALA CYS ARG ASP ASN SEQRES 25 A 328 LEU SER GLN TRP GLU LYS VAL ILE ARG GLY GLU GLU THR SEQRES 26 A 328 ALA THR TRP SEQRES 1 D 328 ASN ALA SER ILE CYS THR SER GLU GLU TRP GLN GLY LEU SEQRES 2 D 328 MET GLN PHE THR LEU PRO VAL ARG LEU CYS LYS GLU ILE SEQRES 3 D 328 GLU LEU PHE HIS PHE ASP ILE GLY PRO PHE GLU ASN MET SEQRES 4 D 328 TRP PRO GLY ILE PHE VAL TYR MET VAL HIS ARG SER CYS SEQRES 5 D 328 GLY THR SER CYS PHE GLU LEU GLU LYS LEU CYS ARG PHE SEQRES 6 D 328 ILE MET SER VAL LYS LYS ASN TYR ARG ARG VAL PRO TYR SEQRES 7 D 328 HIS ASN TRP LYS HIS ALA VAL THR VAL ALA HIS CYS MET SEQRES 8 D 328 TYR ALA ILE LEU GLN ASN ASN HIS THR LEU PHE THR ASP SEQRES 9 D 328 LEU GLU ARG LYS GLY LEU LEU ILE ALA CYS LEU CYS HIS SEQRES 10 D 328 ASP LEU ASP HIS ARG GLY PHE SER ASN SER TYR LEU GLN SEQRES 11 D 328 LYS PHE ASP HIS PRO LEU ALA ALA LEU TYR SER THR SER SEQRES 12 D 328 THR MET GLU GLN HIS HIS PHE SER GLN THR VAL SER ILE SEQRES 13 D 328 LEU GLN LEU GLU GLY HIS ASN ILE PHE SER THR LEU SER SEQRES 14 D 328 SER SER GLU TYR GLU GLN VAL LEU GLU ILE ILE ARG LYS SEQRES 15 D 328 ALA ILE ILE ALA THR ASP LEU ALA LEU TYR PHE GLY ASN SEQRES 16 D 328 ARG LYS GLN LEU GLU GLU MET TYR GLN THR GLY SER LEU SEQRES 17 D 328 ASN LEU ASN ASN GLN SER HIS ARG ASP ARG VAL ILE GLY SEQRES 18 D 328 LEU MET MET THR ALA CYS ASP LEU CYS SER VAL THR LYS SEQRES 19 D 328 LEU TRP PRO VAL THR LYS LEU THR ALA ASN ASP ILE TYR SEQRES 20 D 328 ALA GLU PHE TRP ALA GLU GLY ASP GLU MET LYS LYS LEU SEQRES 21 D 328 GLY ILE GLN PRO ILE PRO MET MET ASP ARG ASP LYS LYS SEQRES 22 D 328 ASP GLU VAL PRO GLN GLY GLN LEU GLY PHE TYR ASN ALA SEQRES 23 D 328 VAL ALA ILE PRO CYS TYR THR THR LEU THR GLN ILE LEU SEQRES 24 D 328 PRO PRO THR GLU PRO LEU LEU LYS ALA CYS ARG ASP ASN SEQRES 25 D 328 LEU SER GLN TRP GLU LYS VAL ILE ARG GLY GLU GLU THR SEQRES 26 D 328 ALA THR TRP HET ZN A1402 1 HET MG A1403 1 HET ZN D1402 1 HET MG D1403 1 HET 3A6 D1769 32 HETNAM ZN ZINC ION HETNAM MG MAGNESIUM ION HETNAM 3A6 3-AMINO-6-FLUORO-2-[4-(2-METHYLPYRIDIN-4-YL)PHENYL]-N- HETNAM 2 3A6 (METHYLSULFONYL)QUINOLINE-4-CARBOXAMIDE FORMUL 3 ZN 2(ZN 2+) FORMUL 4 MG 2(MG 2+) FORMUL 7 3A6 C23 H19 F N4 O3 S FORMUL 8 HOH *105(H2 O) HELIX 1 1 THR A 452 PHE A 462 1 11 HELIX 2 2 PRO A 465 ILE A 472 1 8 HELIX 3 3 ILE A 479 ASN A 484 5 6 HELIX 4 4 MET A 485 GLY A 499 1 15 HELIX 5 5 GLU A 504 ASN A 518 1 15 HELIX 6 6 ASN A 526 ASN A 544 1 19 HELIX 7 7 HIS A 545 PHE A 548 5 4 HELIX 8 8 THR A 549 HIS A 563 1 15 HELIX 9 9 SER A 571 PHE A 578 1 8 HELIX 10 10 HIS A 580 TYR A 586 1 7 HELIX 11 11 SER A 589 GLN A 604 1 16 HELIX 12 12 SER A 615 ALA A 632 1 18 HELIX 13 13 ASP A 634 THR A 651 1 18 HELIX 14 14 ASN A 658 LEU A 675 1 18 HELIX 15 15 CYS A 676 LYS A 680 5 5 HELIX 16 16 LEU A 681 LEU A 706 1 26 HELIX 17 17 ILE A 711 ASP A 715 5 5 HELIX 18 18 ASP A 715 ASP A 720 5 6 HELIX 19 19 GLU A 721 VAL A 733 1 13 HELIX 20 20 VAL A 733 LEU A 745 1 13 HELIX 21 21 THR A 748 ILE A 766 1 19 HELIX 22 22 THR D 452 GLN D 461 1 10 HELIX 23 23 PRO D 465 ILE D 472 1 8 HELIX 24 24 ILE D 479 ASN D 484 5 6 HELIX 25 25 MET D 485 GLY D 499 1 15 HELIX 26 26 GLU D 504 ASN D 518 1 15 HELIX 27 27 ASN D 526 ASN D 544 1 19 HELIX 28 28 THR D 549 HIS D 563 1 15 HELIX 29 29 SER D 571 PHE D 578 1 8 HELIX 30 30 HIS D 580 TYR D 586 1 7 HELIX 31 31 SER D 589 LEU D 605 1 17 HELIX 32 32 SER D 615 ALA D 632 1 18 HELIX 33 33 ASP D 634 GLN D 650 1 17 HELIX 34 34 ASN D 658 LEU D 675 1 18 HELIX 35 35 CYS D 676 LYS D 680 5 5 HELIX 36 36 LEU D 681 LYS D 705 1 25 HELIX 37 37 ILE D 711 ASP D 715 5 5 HELIX 38 38 ASP D 715 ASP D 720 5 6 HELIX 39 39 GLU D 721 VAL D 733 1 13 HELIX 40 40 VAL D 733 LEU D 745 1 13 HELIX 41 41 THR D 748 GLY D 768 1 21 LINK NE2 HIS A 529 ZN ZN A1402 1555 1555 2.18 LINK NE2 HIS A 563 ZN ZN A1402 1555 1555 2.17 LINK OD2 ASP A 564 ZN ZN A1402 1555 1555 2.10 LINK OD1 ASP A 564 MG MG A1403 1555 1555 2.14 LINK OD1 ASP A 674 ZN ZN A1402 1555 1555 2.19 LINK ZN ZN A1402 O HOH A2029 1555 1555 2.09 LINK MG MG A1403 O HOH A2024 1555 1555 2.12 LINK MG MG A1403 O HOH A2028 1555 1555 2.27 LINK MG MG A1403 O HOH A2029 1555 1555 1.91 LINK MG MG A1403 O HOH A2030 1555 1555 1.94 LINK MG MG A1403 O HOH A2034 1555 1555 2.07 LINK NE2 HIS D 529 ZN ZN D1402 1555 1555 2.24 LINK NE2 HIS D 563 ZN ZN D1402 1555 1555 2.16 LINK OD2 ASP D 564 ZN ZN D1402 1555 1555 2.21 LINK OD1 ASP D 564 MG MG D1403 1555 1555 2.13 LINK OD1 ASP D 674 ZN ZN D1402 1555 1555 2.11 LINK ZN ZN D1402 O HOH D2026 1555 1555 2.27 LINK MG MG D1403 O HOH D2022 1555 1555 2.45 LINK MG MG D1403 O HOH D2025 1555 1555 1.94 LINK MG MG D1403 O HOH D2026 1555 1555 1.93 LINK MG MG D1403 O HOH D2027 1555 1555 2.25 LINK MG MG D1403 O HOH D2033 1555 1555 1.97 SITE 1 AC1 5 HIS A 529 HIS A 563 ASP A 564 ASP A 674 SITE 2 AC1 5 HOH A2029 SITE 1 AC2 6 ASP A 564 HOH A2024 HOH A2028 HOH A2029 SITE 2 AC2 6 HOH A2030 HOH A2034 SITE 1 AC3 5 HIS D 529 HIS D 563 ASP D 564 ASP D 674 SITE 2 AC3 5 HOH D2026 SITE 1 AC4 7 ASP D 564 THR D 633 HOH D2022 HOH D2025 SITE 2 AC4 7 HOH D2026 HOH D2027 HOH D2033 SITE 1 AC5 13 LYS A 686 VAL D 678 ILE D 692 TYR D 693 SITE 2 AC5 13 PHE D 696 PRO D 712 MET D 713 LYS D 718 SITE 3 AC5 13 GLU D 721 VAL D 722 GLY D 725 GLN D 726 SITE 4 AC5 13 PHE D 729 CRYST1 49.986 81.694 164.764 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.020006 0.000000 0.000000 0.00000 SCALE2 0.000000 0.012241 0.000000 0.00000 SCALE3 0.000000 0.000000 0.006069 0.00000 MTRIX1 1 -0.174000 -0.943000 -0.284000 -0.04220 1 MTRIX2 1 0.981000 -0.140000 -0.135000 -0.77611 1 MTRIX3 1 0.088000 -0.302000 0.949000 0.05220 1